MGO One Seven’s Haemonetics HAE Stock Holding History

MGO One Seven’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-519	Closed	-$51K	–	911
2018 Q4	$51K	Buy	+519	New	+$54.5K	0.02%	633

Other funds holding HAE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

MGO One Seven's HAE Position: Q1 2019 in Review

MGO One Seven sold out of Haemonetics (HAE) in Q1 2019, closing a stake of 519 shares — an estimated $51K sold.

MGO One Seven first reported a position in HAE in Q4 2018 and held it in 1 quarter. The position peaked at $51K in Q4 2018. 260 funds tracked by Wall St. Rank hold HAE as of Q1 2019.

MGO One Seven reported no remaining Haemonetics position as of Q1 2019 after selling out during the quarter.
MGO One Seven sold 519 Haemonetics shares in Q1 2019, an estimated $51K.
MGO One Seven first reported a position in Haemonetics in Q4 2018 and held it in 1 quarter.
MGO One Seven's Haemonetics position peaked at $51K in Q4 2018.
260 funds tracked by Wall St. Rank held Haemonetics as of Q1 2019.

Based on MGO One Seven's 13F filing for Q1 2019, filed 9 Apr 2019.